"Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research". CNS Drugs. 27 (9): 703–16. 2013. doi:10.1007/s40263-013-0071-0. PMID23757185.
"Is pindolol augmentation effective in depressed patients resistant to selective serotonin reuptake inhibitors? A systematic review and meta-analysis". Hum Psychopharmacol. 30 (3): 132–42. 2015. doi:10.1002/hup.2465. PMID25689398.
"The use of pindolol to potentiate antidepressant medication". J Clin Psychiatry. 59 Suppl 5: 16–23; discussion 24–5. 1998. PMID9635544.
"Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research". CNS Drugs. 27 (9): 703–16. 2013. doi:10.1007/s40263-013-0071-0. PMID23757185.
"Is pindolol augmentation effective in depressed patients resistant to selective serotonin reuptake inhibitors? A systematic review and meta-analysis". Hum Psychopharmacol. 30 (3): 132–42. 2015. doi:10.1002/hup.2465. PMID25689398.